Profiling MAP kinase cysteines for targeted covalent inhibitor design

被引:9
|
作者
Liu, Ruibin [1 ]
Verma, Neha [1 ,2 ]
Henderson, Jack A. [1 ]
Zhan, Shaoqi [1 ]
Shen, Jana [1 ]
机构
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[2] Enzymaster GmbH, Dusseldorf, Germany
来源
RSC MEDICINAL CHEMISTRY | 2022年 / 13卷 / 01期
基金
美国国家卫生研究院;
关键词
PROTEIN-KINASES; BINDING; SITE; ACTIVATION; PARAMETERS; DISCOVERY; KINETICS; PROGRESS; THERAPY; REVEALS;
D O I
10.1039/d1md00277e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitogen-activated protein kinases (MAPK) are important therapeutic targets, and yet no inhibitors have advanced to the market. Here we applied the GPU-accelerated continuous constant pH molecular dynamics (CpHMD) to calculate the pK(a)'s and profile the cysteine reactivities of all 14 MAPKs for assisting the targeted covalent inhibitor design. The simulations not only recapitulated but also rationalized the reactive cysteines in the front pocket of JNK1/2/3 and the extended front pocket of p38 alpha. Interestingly, the DFG - 1 cysteine in the DFG-in conformation of ERK1/ERK2 was found somewhat reactive or unreactive; however, simulations of MKK7 showed that switching to the DFG-out conformation makes the DFG - 1 cysteine reactive, suggesting the advantage of type II covalent inhibitors. Additionally, the simulations prospectively predicted several druggable cysteine and lysine sites, including the alpha H head cysteine in JNK1/3 and DFG + 6 cysteine in JNK2, corroborating the chemical proteomic screening data. Given the low cost and the ability to offer physics-based rationales, we envision CpHMD simulations to complement the chemo-proteomic platform for systematic profiling cysteine reactivities for targeted covalent drug discovery.
引用
收藏
页码:54 / 63
页数:10
相关论文
共 50 条
  • [41] Transcript profiling of a MAP kinase pathway in C-albicans
    Huang, Hao
    Harcus, Doreen
    Whiteway, Malcolm
    MICROBIOLOGICAL RESEARCH, 2008, 163 (04) : 380 - 393
  • [42] Chemical Probes For Histidine Kinase Profiling And Inhibitor Discovery
    Carlson, Erin
    FASEB JOURNAL, 2016, 30
  • [43] Computational reactivity scanning for designing lysine targeted covalent kinase inhibitors
    Liu, Ruibin
    Shen, Jana
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [44] Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors
    Liu, Ruibin
    Yue, Zhi
    Tsai, Cheng-Chieh
    Shen, Jana
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (16) : 6553 - 6560
  • [45] A targeted covalent small molecule inhibitor of HIV-1 fusion
    Zhou, Guangyan
    He, Li
    Li, Kathy H.
    Pedroso, Cassio C. S.
    Gochin, Miriam
    CHEMICAL COMMUNICATIONS, 2021, 57 (37) : 4528 - 4531
  • [46] A MAP KINASE TARGETED BY ENDOTOXIN AND HYPEROSMOLARITY IN MAMMALIAN-CELLS
    HAN, J
    LEE, JD
    BIBBS, L
    ULEVITCH, RJ
    SCIENCE, 1994, 265 (5173) : 808 - 811
  • [47] A Probe-Free Occupancy Assay to Assess a Targeted Covalent Inhibitor of Receptor Tyrosine-Protein Kinase erbB-2
    Xue, Liang
    van Kalken, Daniel
    James, Erika M.
    Giammo, Giulia
    Labenski, Matthew T.
    Cantin, Susan
    Fahnoe, Kelly
    Worm, Karin
    Wang, Zhigang
    Corin, Alan F.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (08) : 2507 - 2515
  • [48] Quantitative design features of the MAP kinase module
    Chapman, S
    Asthagiri, AR
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 248A - 248A
  • [49] A RATIONALE FOR THE DESIGN OF AN INHIBITOR OF TYROSYL KINASE
    YUAN, CJ
    JAKES, S
    ELLIOTT, S
    GRAVES, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (27) : 16205 - 16209
  • [50] Quantitative design features of the MAP kinase module
    Asthagiri, A
    Chapman, S
    FASEB JOURNAL, 2004, 18 (08): : C38 - C38